Hey, you. Meet Vyleesi.
...it’s Now Approved
Vyleesi is the first and only as-needed* treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).
*Administer subcutaneously as needed at least 45 minutes before anticipated sexual activity. The duration of its effect after each dose is unknown. Do not administer more than one dose within 24 hours or more than 8 doses per month.
If your sexual desire is lower than it used to be. If that low desire frustrates you. If you want to want sex again…
Line up now.
Be the first to know when Vyleesi is available.
What is hypoactive sexual desire disorder?
Hypoactive sexual desire disorder (HSDD) is a common, treatable medical condition characterized by ongoing low sexual desire that women find frustrating.
Acquired, generalized HSDD means you have not had low sexual desire in the past and you now have low sexual desire, no matter the sexual activity, situation, or sexual partner.
Here’s what you may be experiencing.
Negative body image
It could impact how you see yourself. (You don’t have to accept this anymore.)
It may make you want to avoid intimate moments. (If you’re missing that closeness, you deserve better.)
It can even impact your confidence. (ICYMI: you are great.)
HSDD Symptom Checker
Think you may have it? Check your symptoms, like decreased sexual desire, and then talk to a healthcare professional.
Find out when it's available.
Vyleesi will be available soon.